EV/EBITDA
11.72
-0.01-0.09%
Wed, 27 Nov 2024 21:07:18 GMT
Summary:
Avanos Medical EV/EBITDA is currently 11.72, with a fall of -0.01 (-0.09%) during the most recent trading day. Over the past year, it has dropped by -8.16 (-41.05%). AVNS EV/EBITDA is now -95.56% below its all-time high of 263.78.AVNS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVNS EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | -0.1% |
1 m1 month | -12.9% |
3 m3 months | -29.6% |
6 m6 months | -30.4% |
ytdytd | -46.1% |
1 y1 year | -41.0% |
5 y5 years | +111.9% |
AVNS EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 13.62 | -13.9% | 10.99 | +6.6% |
3 m | 3 months | 17.17 | -31.7% | 10.99 | +6.6% |
6 m | 6 months | 17.27 | -32.1% | 10.99 | +6.6% |
1 y | 1 year | 21.97 | -46.6% | 10.99 | +6.6% |
3 y | 3 years | 36.45 | -67.8% | -83.85 | +114.0% |
5 y | 5 years | 128.72 | -90.9% | -1349 | +100.9% |
alltime | all time | 263.78 | -95.6% | -1349 | +100.9% |
Avanos Medical EV/EBITDA History
Date | Value |
---|---|
2024 | 11.72(-46.1%) |
2023 | 21.75(+109.3%) |
2022 | 10.39(-70.6%) |
2021 | 35.37(-103.0%) |
2020 | -1167.88(+717.4%) |
Date | Value |
---|---|
2019 | -142.87(-400.3%) |
2018 | 47.57(-64.4%) |
2017 | 133.76(-352.0%) |
2016 | -53.07(+85.2%) |
2015 | -28.66(-301.8%) |
2014 | 14.20 |
FAQ
- What is Avanos Medical EV/EBITDA?
- What is the all time high EV/EBITDA for Avanos Medical?
- What is AVNS EV/EBITDA year-to-date change?
- What is Avanos Medical EV/EBITDA year-on-year change?
What is Avanos Medical EV/EBITDA?
The current EV/EBITDA of AVNS is 11.72
What is the all time high EV/EBITDA for Avanos Medical?
Avanos Medical all-time high EV/EBITDA is 263.78
What is AVNS EV/EBITDA year-to-date change?
Avanos Medical EV/EBITDA has changed by -10.03 (-46.11%) since the beginning of the year
What is Avanos Medical EV/EBITDA year-on-year change?
Over the past year, AVNS EV/EBITDA has changed by -8.16 (-41.05%)